Saturday, April 20, 2024 8:16:29 PM
THAT'S THE BIG PICTURE. They have been involved one way or another in tons of litigation, infighting with past partners, many hearings of all kinds, promises, promises, promises......out and out bold faced lies in the form of PRs, a never ending parade of an army of lawyers, judges, panels, and the supporting cabal. Botton line after all said and done, is most are underwater and the patents have PROVEN themselves to be worthless since their creation over 15 yrs ago. Company can't make a dime ever except for their own pockets. The so called IR guy has only worked for loser OTC pennystocks that have all been duds to my knowledge. The pps bias is ALWAYS downward. There's been a couple pump driven and ipr driven speculative spikes which last for 5 minutes then ALWAYS head back down where it started or lower. The pro sides got nothing except their copycat mantras of "patience is a virtue" and "best position ever", both promulgated by those with self interest and then copy catted for yrs and year's. The company, fully knowing about the bleeding and fully knowing about the affect their selling has had on general shareholder morale, supported by years of fake infomercial so called conference calls, bs PRs, paid so called eZine articles, videos, etc etc.
The bottom line and one that reeks common sense is that if the patents were all that, they'd have been jumped on many times over plus all sorts of licensing, settlements and partnerships. Most don't want to admit it's a big ol farce, especially if they have alot invested. If lord emu of eGipped REALLY was the fiduciary minded ceo he wants you to believe, he wouldn't be so quiet and failing majorly in letting you, the peeps who funded his dream scene. He has shown total disrespect for the retail shareholders, in my opinion.
Where's my 50cents?
All my commentary is to be considered as my personal opinions, to which I am entitled. And there is no proof of said opinions unless I offer it in the comments.
Recent VPLM News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM